Dr Gandhi presents results at AACR 2018 from a trial assessing the response rate, overall survival and progression free survival of non-squamous non-small cell lung cancer patients treated with a combination of pembrolizumab and chemotherapy.

For more on these results, watch her interview with ecancer.